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Background: A study was conducted to evaluate the effect of indoxacarb applied to cats on adult cat fleas,
Ctenocephalides felis, flea egg production and adult flea emergence.
Methods: Sixteen cats were selected for the study and allocated to two treatment groups. Eight cats were treated
with a 19.5% w/v topical spot-on solution of indoxacarb on day 0 and eight cats served as untreated controls. Each
cat was infested with 50 fleas on Days −2, 7, 14, 21, 28, 35 and 42. On Days 1, 2, and 3, and at 2 and 3 days after
each post treatment reinfestation flea eggs were collected from the pan under each cat cage. Eggs were counted
and viability assessed by evaluating adult flea emergence 28 days after egg collection. Three days after treatment or
infestation, each cat was combed to remove and count live fleas.
Results: Treatment with indoxacarb provided 100% efficacy following infestations on day −2, 7, 14, 21 and 28 and
efficacy was 99.6% following infestations on days 35 and 42. Egg production from indoxacarb treated cats was
reduced by 99.9% within 72 hours of treatment. For subsequent infestations no eggs were produced from treated
cats from day 8 through day 30. Egg production was still reduced by ≥95.8% through day 45. Indoxacarb treatment
also reduced adult flea emergence from eggs for 5 weeks after treatment. The combination of reduction in egg
numbers and egg viability from indoxacarb treated cats reduced predicted flea emergence by 100% from days
2 – 31 and 99.9%, 100%, 96.4% and 99.0% on days 37, 38, 44 and 45, respectively.
Conclusions: A topical spot-on formulation of indoxacarb provided ≥99.6% efficacy against flea infestations on cats
for 6 weeks following a single treatment. Indoxacarb also eliminated or markedly reduced egg production for the
entire evaluation period and reduced the viability of the few eggs that were produced from Day 1 through Day 38.
Given indoxacarb’s effect on adult fleas, egg production and egg viability; this formulation can interrupt flea
reproduction on treated cats for at least 6 weeks after treatment.
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The cat flea, Ctenocephalides felis, is the most important
ectoparasite of dogs and cats in most areas of the world
[1]. Once cat fleas acquire a host, they mate and start
laying eggs within 24 – 48 hours [2,3]. Fleas deposit
their eggs into the haircoat of the dog or cat with the
eggs dropping off into the premises where within a few
weeks they develop into adult fleas [3]. Since female cat* Correspondence: Dryden@vet.k-state.edu
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reproduction in any medium, provided the orfleas can produce 40 – 50 eggs/day it does not take long
for massive numbers of flea eggs and ultimately emer-
ging fleas to accumulate within the premises [3].
Currently, most flea control is based on residual top-
ical spot-on treatments or oral medications [4-6]. The
primary focus of these topical and systemic flea control
efforts is to force fleas into “extinction” in a localized en-
vironment (home or yard) by preventing reproduction
[6,7]. Eradication of an existing flea infestation is accom-
plished either by killing newly acquired fleas with a re-
sidual adulticide before they can initiate reproduction
and/or affecting the viability of the eggs they produceLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cidal compounds [4]. In order for a topical or systemic
insecticide to prevent egg production, the residual activ-
ity must be sufficient to kill or render moribund newly
acquired fleas within 24 hours. A number of in-home
and multicentric studies on three continents have de-
monstrated that this approach to flea control can be suc-
cessful [6,8-13].
Indoxacarb is a novel oxadiazine insecticide that con-
trols a broad spectrum of insects and was originally
developed for use on a variety of plants including vegeta-
bles, fruit trees, cotton and row crops [14]. Indoxacarb
is a pro-insecticide that is metabolized within the insect
to a more active form: an N-decarbomethoxylated me-
tabolite of indoxacarb. This metabolic conversion of
indoxacarb, known as bioactivation, is attributed to ac-
tions of esterase and amidase enzymes within the insect
[15,16]. The active metabolite of indoxacarb exerts its ef-
fect by blocking the voltage-gated sodium ion channels
in insects and is at least forty times more potent than
parent indoxacarb in its ability to block sodium channel
ion current [15-17]. Mammals exhibit minimal bioac-
tivation of indoxacarb and sodium channel binding stu-
dies in rats show the active indoxacarb metabolite has
much weaker potency against mammalian sodium chan-
nels than insect channels [16,18].
This study was undertaken to evaluate the efficacy of a
recently developed spot-on formulation of indoxacarb
applied to cats against adult fleas, flea egg production
and development of fleas from eggs to adults.
Methods
Animals and housing
Nineteen (10m:9f; > 6mo; 2.7 to 4.2 kg), purpose bred
domestic shorthair cats were used in this study. Cats
used in this investigation had no exposure to ecto-
parasiticides prior to treatment and were in good health
throughout the study. Cats were housed individually in
standard stainless cages steel with solid sides and back,
with a steel barred door. Cats were physically separated
by the solid stainless steel cage walls. Cats were fed a
commercial dry cat-food ration. Water was available ad
libitum. Physical examinations were conducted by a li-
censed veterinarian prior to the initial flea infestation
and cats were determined to be in good health and free
of any preexisiting dermal lesions. All animal care proce-
dures conformed to guidelines established by the Institu-
tional Animal Care and Use Committee at Kansas State
University (Approval No. 3124).
Animal selection and randomization
On Day −8, all cats were infested with 50 adult cat fleas,
C. felis, (KS1 strain) 1 to 5 days post emergence. On
Day −5, flea comb counts were performed to evaluatethe susceptibility of each cat to maintain experimental
infestations and for random allocation of the cats to the
treatment groups. Cats were combed with a fine-toothed
flea comb having 12 to 13 teeth/cm. Flea removal was
achieved by combing each cat thoroughly for 10 mi-
nutes. If five or more fleas were recovered during this
period, the cat was combed for an additional 5 minutes.
If any fleas were recovered during the second combing
period, the cats were combed for an additional 5 minutes.
Personnel conducting flea combing and flea counts were
blinded to treatment groups. The 16 cats (7m:9f) with the
highest pre-treatment flea counts were used for the study.
Within gender, cats were ranked from highest to lowest
flea count, with the female cat with lowest flea number
placed in male gender grouping, and blocked in two
groups containing 8 cats each.
Treatments
Cats (4m:4f) in treatment group 1 were treated topically
with indoxacarb (2 – 4.0 kg were treated with 0.51 mL
and cats > 4.1 kg were treated with 1.03 mL indoxacarb,
19.5% w/v; ACTIVYL® Merck Animal Health) applied
using the commercial product pipette or a syringe.
Treatment was administered by parting the hair with the
tip of the pipette or syringe at the base of the skull of
the cat and the entire contents were applied directly to
the skin. Cats (3m:5f ) in treatment group 2 served as
untreated controls. Cats were observed following treat-
ment for any adverse events associated the treatments.
Efficacy evaluations
On Days −2, 7, 14, 21, 28, 35, and 42, each cat was
infested with approximately 50 unfed cat fleas, C. felis
(KS1 strain). On Days 1, 2, and 3, and at 2 and 3 days
after each post treatment reinfestation flea eggs were
collected from the pan under each cat cage. Prior to the
egg collections, cats were massaged/brushed vigorously
by hand for ~20 seconds in their cages to dislodge any
flea eggs from the cat’s hair coat, allowing the eggs to fall
into the drop pan below the cage. Eggs collected were
counted by placing the eggs in a glass Petri dish and
counted under a dissecting microscope. At approxi-
mately 72 hours after treatment or infestation, each cat
was combed to remove and count live fleas. Viability of
eggs was determined by placing up to 100 eggs into glass
Petri dishes containing flea growth media and holding in
a rearing chamber (I-30B, Percival Manufacturing Co.,
Boone, IA) at 27-28°C, 70-80% relative humidity, 24
hours dark. If less than 100 eggs were collected, the en-
tire sample was placed into the Petri dish containing flea
growth media and similarly processed. At 10 – 12 days
after egg collection, pupae (and any larvae that had not
completed cocoon formation) were sifted from the me-
dia and placed into plastic vials with lids. Adult emergence
Table 1 Geometric mean adult flea counts and percent
efficacy relative to non-treated controls for cats treated
with a 19.5% w/v indoxacarb topical spot-on
Study day Mean # of Fleas1,2
Non-treated controls3 Indoxacarb3
3 27.2 a 0.0 b (100.0)4
10 19.3 a 0.0 b (100.0)
17 25.6 a 0.0 b (100.0)
24 28.0 a 0.0 b (100.0)
31 24.7 a 0.0 b (100.0)
38 25.7 a 0.1 b (99.6)
45 20.8 a 0.1 b (99.6)
1 Each cat was infested with 50 adult Ctenocephalides felis from the KS1 strain
on days −2, 7, 14, 21, 28, 35 & 42.
2Geometric mean # of fleas recovered from cats per treatment group.
3Each of 8 cats in the control group received no treatment. Each of 8 cats in
the 19.5% w/v indoxacarb group were administered the topical spot-on
according to label directions on Day 0.
4% efficacy = ((geometric mean live adult flea count control-geometric mean live
adult flea count treatment)/geometric mean live adult flea count control) × 100.
a, b geometric means across rows with unlike letter superscripts are
significantly different (P < 0.001).
Table 2 Geometric mean flea egg counts and percent
efficacy relative to non-treated controls for cats treated
with a 19.5% w/v indoxacarb topical spot-on
Non-treated controls1,2 Indoxacarb1,2
Day of egg
collection
Mean # of eggs3 Mean # of eggs Efficacy4
1 654.2 a 220.9 a 66.2
2 627.8 a 7.2 b 98.9
3 589.8 a 0.6 b 99.9
9 650.7 a 0.0 b 100.0
10 957.6 a 0.0 b 100.0
16 459.1 a 0.0 b 100.0
17 686.4 a 0.0 b 100.0
23 739.8 a 0.0 b 100.0
24 1086.1 a 0.0 b 100.0
30 566.5 a 0.0 b 100.0
31 732.1 a 0.1 b 99.9
37 491.2 a 0.7 b 99.9
38 577.9 a 0.1 b 99.9
44 229.7 a 9.7 b 95.8
45 508.4 a 6.8 b 98.7
1Each of 8 cats in the control group received no treatment. Each of 8 cats in
the 19.5% w/v indoxacarb group were administered the topical spot-on
according to label directions on Day 0.
2 Each cat was infested with 50 adult Ctenocephalides felis from the KS1 strain
on days −2, 7, 14, 21, 28, 35 & 42.
3Geometric mean # of eggs recovered from cats per treatment group.
4% efficacy = ((geometric mean # eggs control-geometric mean # eggs
treatment)/geometric mean # eggs control) × 100.
a,b Geometric means across rows with unlike letter superscripts are
significantly different (P < 0.001).
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egg collection. Personnel conducting comb counts, egg
collections and viability assessments were blinded to treat-
ment group allocation.
Data analysis
Data at each time point were analyzed separately. The
adult flea and egg count data were transformed prior to
analysis using the Y = loge(x + 1) transformation. The log
transformed data were analyzed by a mixed linear model
including treatment as the fixed effect; and block as the
random effect. Least squares means were used for treat-
ment comparisons and were back transformed to obtain
the estimates of geometric mean flea and egg counts.
Percentages of the emerging adult flea count were ana-
lyzed by a mixed linear model including treatment as
the fixed effect; and block as the random effect. A two-
tailed test was used for the comparison between groups.
Statistical significance was declared when p < 0.05. The
primary software was SAS version 9.3.
Percent control of adult fleas was calculated using geo-
metric means with Abbott’s formula:
Efficacy %ð Þ ¼ 100 MCMTð Þ=MC
Where:
- MC is the geometric mean number of total adult live
fleas on untreated cats
- MT is the geometric mean number of total adult live
fleas on treated cats.
The percent control of egg production and egg via-
bility were also calculated using Abbott’s formula by
adjusting the mean number of eggs produced and mean
percent of emergent fleas from treated cats with the
mean number of eggs produced and mean percent of
emergent fleas produced by fleas on untreated control
cats.
Results
All cats included in the study demonstrated adequate
pretreatment flea retention with day −5 flea counts ran-
ging from 16 – 38 fleas/cat. Nontreated cats also main-
tained adequate flea infestations throughout the study
with geometric mean flea counts ranging from 19.3 to
28.0 (Table 1).
Cats in the indoxacarb treatment group were adminis-
tered an average of 33.7 mg/kg (27.3 - 47.8 mg/kg) indo-
xacarb. This single dose of indoxacarb produced highly
significant reductions in geometric mean flea counts on
treated cats throughout the entire 45 days of the study
(P < 0.001, Table 1). Treatment with indoxacarb provided
100% efficacy following infestations on day −2, 7, 14,
21 and 28 and 99.6% reduction in geometric mean
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(Table 1).
Geometric mean flea egg counts for the indoxacarb-
treated cats were also significantly lower than those for
nontreated controls at all post-treatment evaluations
(P < 0.001, Table 2). Egg production from indoxacarb
treated cats was reduced by 66.2% within 24 hours after
treatment and 99.9% within 72 hours of treatment. For
subsequent infestations egg production was non-existent
from treated cats out to day 30 and 99.9% on day 31
relative to nontreated cats (Table 2). Egg production was
still markedly reduced by 95.8% and 98.7% on days 44
and 45, respectively. The geometric mean number of
eggs produced from fleas on control cats from day 9
through day 45 post-treatment ranged from 229.7 -
1,086.1. Whereas, the geometric mean number of eggs
from indoxacarb treated cats was highest on day 44 at
9.7 eggs/cat (Table 2).
Based on percent adult emergence, indoxacarb treat-
ment also had an apparent lethal effect on the viability
of flea eggs collected from treated cats on days 1–3 and
on days 31 and 38 (P < 0.001, Table 3). Since no eggs
were collected from indoxacarb treated cats from days
9 – 30 no percent adult flea emergence analysis could beTable 3 Geometric mean percent adult emergence, predicted
non-treated controls for predicted adult flea emergence from
indoxacarb topical spot-on
Non-treated controls1,2
Study day3 % Adult emergence4 Predicted emergence5
1 50.1a 327.9
2 46.1a 289.6
3 67.0a 395.2
9 77.1 501.8
10 79.8 763.7
16 75.3 345.5
17 76.4 524.2
23 84.3 623.2
24 83.6 908.2
30 77.0 436.2
31 85.2a 604.0
37 75.4a 370.2
38 63.7a 388.6
44 77.3a 177.5
45 82.3a 418.1
1 Each of 8 cats in the control group received no treatment. Each of 8 cats in the 19
label directions on Day 0.
2 Each cat was infested with 50 adult Ctenocephalides felis from the KS1 strain on d
3 Days post-treatment that eggs were collected.
4 % Adult emergence = (# of adults emerging/# of eggs collected) × 100.
5 Predicted emergence = (% emergence × geometric mean # eggs collected from T
6 % Efficacy = ((predicted adult emergence control-predicted adult emergence treat
NE = no flea eggs collected.
a,.b Values across rows with unlike superscripts are significantly different (P < 0.05).conducted. A direct effect on egg viability based on per-
cent adult emergence was not observed on post-treatment
days 44 and 45. However when egg viability is considered
along with the marked reduction in egg numbers, in-
doxacarb did demonstrate a marked effect upon the re-
productive success of the fleas even at post-treatment day
45 (Table 3). The combination of the geometric mean
number of eggs produced and the percent adult emer-
gence from those eggs results in the predicted adult emer-
gence or reproductive success. The predicted adult
emergence from eggs produced by fleas on the untreated
control cats ranged from 177.5 – 908.2 emerging fleas/cat.
Whereas the reduction in predicted flea emergence from
indoxacarb treated cats was 100% from days 2 – 31 and
was still 96.8% and 99.0% on days 44 and 45, respectively
(Table 3).
There were no adverse events associated with indoxa-
carb treatments in this study.
Discussion
Veterinarians and pet owners should expect that when
correctly applied indoxacarb spot-on will control the
existing flea burden on a cat and that there should be a
rapid reduction in egg production from the existing fleaadult emergence and percent efficacy relative to
eggs collected from cats treated with a 19.5% w/v
Indoxacarb1,2
% Adult emergence4 Predicted emergence5 Efficacy6
4.6 b 10.2 96.9
0.0b 0.0 100.0
0.0b 0.0 100.0
NE 0.0 100.0
NE 0.0 100.0
NE 0.0 100.0
NE 0.0 100.0
NE 0.0 100.0
NE 0.0 100.0
NE 0.0 100.0
0.0b 0.0 100.0
20.0b 0.1 99.9
0.0b 0.0 100.0
66.1a 6.4 96.4
62.5a 4.3 99.0
.5% w/v indoxacarb group were administered the topical spot-on according to
ays −2, 7, 14, 21, 28, 35 & 42.
able 2).
ment)/geometric mean % adult emergence control) × 100.
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tion was almost completely halted (98.9% reduction).
Since none of those eggs produced adult fleas no dis-
semination of viable eggs occurred from treated cats
within 2 days of treatment.
Most currently available residual topical spot-on and
systemic insecticide formulations are marketed to pro-
vide at least 30 days of effective flea control. Indoxacarb
spot-on certainly provided and exceeded that level of con-
trol. A single application of indoxacarb provided ≥99.6%
control of adult cat fleas on cats for at least 45 days after
treatment.
Following treatment, egg production from weekly flea
reinfestations was reduced by ≥99.9% at least 5 weeks.
Consumption of blood is necessary before cat fleas can
initiate reproduction and egg production does not begin
until 24–48 hours after females take their first blood
meal [1,2]. Therefore, if a residual insecticide can kill or
produce toxicity in newly acquired fleas within 24 hours,
egg production should be markedly reduced or halted.
While this study did not evaluate the residual speed of
kill of indoxacarb or reduction of blood consumption by
adult fleas, it did demonstrate that indoxacarb had a
profound effect upon egg production. This indirectly in-
dicates that indoxacarb is rapidly toxic to fleas and thus
markedly reduces blood feeding by fleas.
Indoxacarb also had an effect upon adult flea emer-
gence from eggs. While this study did not evaluate egg
hatch directly it is anticipated that the effect of in-
doxacarb was on egg viability. Eggs collected from trays
under treated cats were sorted and removed from all
debris from those cats. The eggs were subsequently
placed into standard rearing media. Following this pro-
cedure any larvae hatching from those eggs would have
had no further contact with indoxacarb. Similar marked
lethal effect on egg viability by a flea adulticide has been
previously observed with selamectin [19].
Effective residual flea adulticides should have sufficient
residual activity to provide for continuing kill of most if
not all the newly emerging fleas that jump onto the
treated pet between applications. If a flea product also
has an effect upon the viability of the eggs produced by
any female flea surviving the adulticidal effect, that
product would markedly suppress the reproductive suc-
cess of a flea population [6,7]. In this study indoxacarb
demonstrated marked flea kill, profound reduction in
egg production and apparent ovicidal activity, as has
been observed in other insect species [15]. This com-
bination of attributes provided ≥99.9% reduction in
reproductive success (predicted emergence) for 5 weeks
following a single application of indoxacarb. Proper
application of indoxacarb to cats in a flea infested
home should effectively drive the flea population to
extinction.This study was conducted using the KS1 flea strain.
Several previous studies have demonstrated that this
strain has reduced susceptibility or outright resistance to
carbaryl, chlorpyriphos, fenthion, fipronil, imidacloprid,
permethrin, pyrethrins, and spinosad [3,19-24]. This stu-
dy showed that indoxacarb performed well against this
KS-1 flea strain.
Conclusions
A topical spot-on formulation of indoxacarb provided
100% efficacy against flea infestations on cats for 4
weeks following a single treatment and was still provi-
ding 99.6% reduction in flea counts through week 6.
Indoxacarb eliminated or markedly reduced egg produc-
tion for the entire evaluation period. The formulation
also reduced the viability of the few eggs that were pro-
duced through Day 38. Given indoxacarb’s effect on
adult fleas, egg production and egg viability; it appears
this formulation can interrupt flea reproduction for at
least 6 weeks after treatment.
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